The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer

BACKGROUND: Decision‐making regarding adjuvant chemotherapy for early‐stage breast cancer can be guided by genomic assays such as OncotypeDX. The concordance of expected clinical decisions guided by OncotypeDX and prognostication online tools such as PREDICT is unknown. METHODS: We performed a retro...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Med
Main Authors: Goldstein, Daniel A., Mayer, Chen, Shochat, Tzippy, Reinhorn, Daniel, Moore, Assaf, Sarfaty, Michal, Yerushalmi, Rinat, Goldvaser, Hadar
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Clinical Cancer Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333833/
https://ncbi.nlm.nih.gov/pubmed/32372569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3088
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki